(BPT) - In the United States there are nearly 26 million people with diabetes and one of the most common complications of the condition is diabetic peripheral neuropathy (DPN), a form of nerve …
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you are a digital subscriber with an active subscription, or you are a print subscriber who had access to our previous wesbite, then you already have an account here. Just reset your password if you have not yet logged in to your account on this new site.
If you are a current print subscriber and did not have a user account on our previous website, you can set up a free website account by clicking here.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
The survey found that 69 percent of HCPs and 56 percent of people with painful DPN report that DPN symptoms can be difficult to describe. Among those suffering from painful DPN, 81 percent say the pain is different from other kinds of pain they are used to experiencing, and 41 percent report that they have been definitively diagnosed with DPN. Additionally, results showed that 83 percent of people with DPN symptoms report experiencing painful symptoms, however, on average, HCPs estimate that only 41 percent of their patients with DPN experience pain. These results underscore a communication gap between people living with diabetic nerve pain and their HCP, which can impact or delay diagnosis. To help people with diabetes and HCPs engage in more productive discussions about DPN and its symptoms, the American Chronic Pain Association and Pfizer Inc. launched an educational program called "Diabetic Nerve Pain: Starting the Dialogue,” which includes helpful tools and resources, including a conversation guide that people with diabetic nerve pain can print and bring to their doctor’s office. By bridging the communications gap, people with diabetes and HCPs can work together to diagnosis and treat this painful condition. To access resources and other information about living with painful DPN, visit: www.DiabetesPainHelp.com and www.TheACPA.org. This educational initiative was funded by Pfizer Inc. Awareness and education are key to bridging the communication gap between people with diabetic nerve pain and healthcare providers